These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6439208)

  • 1. Prolonged activation of rat lung ornithine decarboxylase in monocrotaline-induced pulmonary hypertension.
    Olson JW; Altiere RJ; Gillespie MN
    Biochem Pharmacol; 1984 Nov; 33(22):3633-7. PubMed ID: 6439208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
    Olson JW; Orlinska U; Gillespie MN
    Biochem Pharmacol; 1989 Sep; 38(17):2903-10. PubMed ID: 2505777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyamines and the development of monocrotaline-induced pulmonary hypertension.
    Olson JW; Hacker AD; Altiere RJ; Gillespie MN
    Am J Physiol; 1984 Oct; 247(4 Pt 2):H682-5. PubMed ID: 6437245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
    Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylated polyamines in lungs from rats with monocrotaline-induced pneumotoxicity.
    Orlinska U; Olson JW; Gebb SA; Gillespie MN
    Fundam Appl Toxicol; 1989 Aug; 13(2):277-84. PubMed ID: 2507383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of polyamine biosynthesis prevents monocrotaline-induced pulmonary edema and arterial medial thickening.
    Olson JW; Atkinson JE; Hacker AD; Altiere RJ; Gillespie MN
    Toxicol Appl Pharmacol; 1985 Oct; 81(1):91-9. PubMed ID: 3931300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
    Hacker AD
    Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE
    Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U; Olson JW; Gillespie MN
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of deoxyribonucleic acid synthesis by difluoromethylornithine. Role of polyamine metabolism in monocrotaline-induced pulmonary hypertension.
    Hacker AD
    Biochem Pharmacol; 1992 Sep; 44(5):965-71. PubMed ID: 1530663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
    Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine.
    Kay JM; Keane PM; Suyama KL
    Respiration; 1985; 47(1):48-56. PubMed ID: 3156395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of lung polyamine accumulation in chronic hypoxic pulmonary hypertension.
    Shiao RT; Kostenbauder HB; Olson JW; Gillespie MN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):L351-8. PubMed ID: 2148056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
    Schultze AE; Emeis JJ; Roth RA
    Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension.
    Stenmark KR; Morganroth ML; Remigio LK; Voelkel NF; Murphy RC; Henson PM; Mathias MM; Reeves JT
    Am J Physiol; 1985 Jun; 248(6 Pt 2):H859-66. PubMed ID: 3923843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 bioactivity in the lungs of rats with monocrotaline-induced pulmonary hypertension.
    Gillespie MN; Goldblum SE; Cohen DA; McClain CJ
    Proc Soc Exp Biol Med; 1988 Jan; 187(1):26-32. PubMed ID: 3124119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.
    Sugita T; Hyers TM; Dauber IM; Wagner WW; McMurtry IF; Reeves JT
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Feb; 54(2):371-4. PubMed ID: 6219974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.